Waters ACQUITY UPLC H-Class PLUS Bio

Brochures and specifications | 2020 | WatersInstrumentation
HPLC
Industries
Manufacturer
Waters

Significance of the Topic


The detailed characterization of biotherapeutics is critical for ensuring product safety, efficacy, and stability.
Advances in liquid chromatography are essential to resolve complex protein structures, detect low‐level impurities, and support regulatory requirements in biopharma QC and R&D.

Objectives and Study Overview


This evaluation examines the performance and flexibility of the ACQUITY UPLC H-Class PLUS Bio System for high-resolution bioseparations.
The primary goals are to demonstrate:
  • Compatibility with multiple chromatographic modes (IEX, SEC, HILIC, HIC, RP, MDLC)
  • Enhanced separation resolution and sensitivity using UPLC technology
  • Robust operation with bio-inert flow paths under demanding buffer conditions

Methodology and Instrumentation


The system integrates UPLC-optimized small-particle columns with precise quaternary or binary solvent delivery and a flow-through-needle injector to minimize carryover.
Key methodological features include:
  • Auto•Blend Plus for on-demand mobile phase generation by pH, ionic strength, or organic content
  • Gradient SmartStart for seamless method transfer from legacy LC platforms
  • Low system dispersion (band spread <10 µL) to preserve chromatographic resolution

Instrumentation


  • ACQUITY UPLC H-Class PLUS Bio System with bio-inert, iron-free flow path
  • BioQuaternary and bioBinary Solvent Managers (up to 4 solvents, optional 6-solvent select valve)
  • Flow-through-needle injector (0.1–1000 µL) with ultra-low carryover
  • Sample Organizer for vials and ANSI plates; temperature-controlled fraction collector
  • Detectors: PDA, UV/Vis, fluorescence, refractive index, ELSD, MS
  • Support for analytical columns up to 300 mm with eCord Intelligent Chip Temperature Control

Key Results and Discussion


1. Peptide Mapping and Protein Separations
• UPLC BEH Peptide columns delivered five-run overlay of infliximab with highly reproducible retention times and peak shapes.

2. Size Exclusion Chromatography (SEC)
• ACQUITY UPLC BEH SEC (450 Å, 2.5 µm) resolved monomer and dimer species with Rs = 2.49 under 0.35 mL/min, improving on conventional HPLC (Rs = 1.42).

3. Hydrophobic Interaction Chromatography (HIC)
• Six-protein standard separated on Protein-Pak Hi Res HIC column using high ionic strength mobile phases, demonstrating robust retention and peak symmetry.

4. Hydrophilic Interaction Chromatography (HILIC)
• RapiFluor-MS-labeled glycans separated in under 30 min on UPLC BEH Amide 1.7 µm column vs. 120 min on HPLC, showing superior speed and resolution.

Benefits and Practical Applications


The system supports a broad spectrum of biopharma assays:
  • Peptide mapping and intact protein analysis
  • Aggregate and fragment detection by SEC
  • Charge variant profiling by IEX
  • Glycan and glycopeptide analysis by HILIC
  • ADC and difficult hydrophobic separations by HIC
  • Multidimensional LC workflows for enhanced characterization depth

Future Trends and Potential Applications


Emerging developments may include:
  • Deeper integration with high-resolution mass spectrometry and multidimensional platforms
  • Automated method scouting using AI-driven solvent and column selection
  • Expanded bio-inert materials for challenging buffers and denaturants
  • High-throughput QC workflows for biosimilar and gene therapy products

Conclusion


The ACQUITY UPLC H-Class PLUS Bio System offers unparalleled resolution, flexibility, and robustness for modern biotherapeutic analyses.
Its combination of low-dispersion flow paths, on-demand mobile phase blending, and versatile detection addresses critical QC and R&D needs while facilitating rapid method transfer and development.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Data is the common currency: What does it take to harmonize technologies and workflows across biopharmaceutical organizations?
ACQUITY UPLC H-Class Bio System
Demonstrating a Fit-for-Purpose Solution for  Biopharmaceutical Separations with the  ACQUITY UPLC H-Class PLUS Bio Binary  System
BIOSEPARATIONS - APPLICATIONS NOTEBOOK